Fermion develops and manufactures generic APIs for the global market. We have a long and successful history in the generic business with a strong position in the US, European and Japanese markets. We supply our APIs increasingly also to fast growing markets including India and China.

Our customer base consists of over 200 pharmaceutical companies including all major generic pharma players. Our long presence in the global market has laid an excellent basis for our compliance in terms of GMP, regulatory affairs and product quality.

Our portfolio consists of over 30 generic APIs, with a third of these developed during the last 10 years. Our ongoing and new development projects focus on respiratory and oncology therapeutic areas.